Management of EMZL of the ocular adnexa – Mini Review

Ocular adnexal Lymphomas comprise approximately 1% to 2% of non-Hodgkin lymphomas (NHLs) and 8% of extranodal lymphomas. The most common subtype, accounting for up to 80% of cases of primary ocular adnexal lymphoma (POAL), is marginal zone lymphoma of mucosa-associated Read More …

Rituximab Maintenance in NHLs – Mini Review

Author: Sujeet Kumar   @sujeethemat Rituximab is given as maintenance therapy in NHLs, although benefits of maintenance rituximab (MR) are still unclear for many NHLs and regimens and durations are confusing. My attempt to simplify this is here. FOLLICULAR LYMPHOMA [1] Read More …